Signaling Pathways - PRMT - Insulin and Insulin-like Receptors - ERK - Sphingosine kinases (SphKs)
清除全部
- B6182 GSK591Target: PRMTSummary: PRMT5抑制剂
- B1106 VRT752271Target: ERKSummary: ERK1/ERK2 inhibitor
- B1298 K145Target: Sphingosine kinases (SphKs)Summary: SphK2抑制剂
- B2226 SKI IITarget: Sphingosine kinases (SphKs)Summary: 鞘氨醇激酶(SK)抑制剂
- A8616 A-674563Target: Cyclin-Dependent Kinases|Akt|GSK-3|ERK|PKC|PKA|RSKSummary: Akt1 / PKA / CDK2的强效选择性抑制剂
- A8440 GSK1838705ATarget: Insulin and Insulin-like Receptors|ALKSummary: ATP竞争性IGF-IR/IR/ALK抑制剂
- A8304 FR 180204Target: ERKSummary: ERK inhibitor
- A5801 BIX 02189Target: MEK|ERKSummary: MEK5抑制剂
- A1302 GSK1904529ATarget: Insulin and Insulin-like ReceptorsSummary: IGF-1R/IR 选择性抑制剂
- A1185 BMS-754807Target: Insulin and Insulin-like ReceptorsSummary: 有效的、选择性的IGF-1R和InsR抑制剂